Literature DB >> 25628412

Opinion: Control vs. eradication: applying infectious disease treatment strategies to cancer.

Gunther Jansen1, Robert Gatenby2, C Athena Aktipis3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25628412      PMCID： PMC4313808          DOI： 10.1073/pnas.1420297111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  18 in total

1.  Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model.

Authors:  Louise D Christensen; Maria van Gennip; Tim H Jakobsen; Morten Alhede; Hans Petter Hougen; Niels Høiby; Thomas Bjarnsholt; Michael Givskov
Journal:  J Antimicrob Chemother       Date:  2012-02-01       Impact factor: 5.790

Review 2.  Anti-virulence strategies to combat bacteria-mediated disease.

Authors:  David A Rasko; Vanessa Sperandio
Journal:  Nat Rev Drug Discov       Date:  2010-01-18       Impact factor: 84.694

3.  Defeating pathogen drug resistance: guidance from evolutionary theory.

Authors:  John W Pepper
Journal:  Evolution       Date:  2008-09-18       Impact factor: 3.694

Review 4.  Targeting virulence: can we make evolution-proof drugs?

Authors:  Richard C Allen; Roman Popat; Stephen P Diggle; Sam P Brown
Journal:  Nat Rev Microbiol       Date:  2014-04       Impact factor: 60.633

Review 5.  Clonal evolution in cancer.

Authors:  Mel Greaves; Carlo C Maley
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

6.  Bicarbonate increases tumor pH and inhibits spontaneous metastases.

Authors:  Ian F Robey; Brenda K Baggett; Nathaniel D Kirkpatrick; Denise J Roe; Julie Dosescu; Bonnie F Sloane; Arig Ibrahim Hashim; David L Morse; Natarajan Raghunand; Robert A Gatenby; Robert J Gillies
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

7.  Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity.

Authors:  Francesco Imperi; Francesco Massai; Marcella Facchini; Emanuela Frangipani; Daniela Visaggio; Livia Leoni; Alessandra Bragonzi; Paolo Visca
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

8.  Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice.

Authors:  H W Hann; M W Stahlhut; B S Blumberg
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

9.  Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: simulating benign cell boosters and selection for chemosensitivity.

Authors:  Carlo C Maley; Brian J Reid; Stephanie Forrest
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-08       Impact factor: 4.254

10.  When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transition.

Authors:  Rafael Pena-Miller; David Laehnemann; Gunther Jansen; Ayari Fuentes-Hernandez; Philip Rosenstiel; Hinrich Schulenburg; Robert Beardmore
Journal:  PLoS Biol       Date:  2013-04-23       Impact factor: 8.029
View more
  8 in total

Review 1.  The Evolution and Ecology of Resistance in Cancer Therapy.

Authors:  Robert Gatenby; Joel Brown
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

Review 2.  Integrating evolutionary dynamics into cancer therapy.

Authors:  Robert A Gatenby; Joel S Brown
Journal:  Nat Rev Clin Oncol       Date:  2020-07-22       Impact factor: 66.675

Review 3.  Application of Evolutionary Principles to Cancer Therapy.

Authors:  Pedro M Enriquez-Navas; Jonathan W Wojtkowiak; Robert A Gatenby
Journal:  Cancer Res       Date:  2015-11-02       Impact factor: 12.701

4.  Dynamics of preventive vs post-diagnostic cancer control using low-impact measures.

Authors:  Andrei R Akhmetzhanov; Michael E Hochberg
Journal:  Elife       Date:  2015-06-25       Impact factor: 8.140

5.  Harbouring public good mutants within a pathogen population can increase both fitness and virulence.

Authors:  Richard J Lindsay; Michael J Kershaw; Bogna J Pawlowska; Nicholas J Talbot; Ivana Gudelj
Journal:  Elife       Date:  2016-12-28       Impact factor: 8.140

6.  Contrasting the impact of cytotoxic and cytostatic drug therapies on tumour progression.

Authors:  Jani V Anttila; Mikhail Shubin; Johannes Cairns; Florian Borse; Qingli Guo; Tommi Mononen; Ignacio Vázquez-García; Otto Pulkkinen; Ville Mustonen
Journal:  PLoS Comput Biol       Date:  2019-11-18       Impact factor: 4.475

7.  Infectious cancers.

Authors:  Robert M Hurwitz
Journal:  Dermatol Pract Concept       Date:  2015-07-31

8.  Primary and metastatic tumor dormancy as a result of population heterogeneity.

Authors:  Irina Kareva
Journal:  Biol Direct       Date:  2016-08-23       Impact factor: 4.540
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.